Mitochondrial mechanisms of neural cell death and neuroprotective interventions in Parkinson's disease

Annals of the New York Academy of Sciences

Volumn 991, Issue , 2003, Pages 111-119

  Fiskum, Gary ^a   Starkov, Anatoly ^a,c   Polster, Brian M ^a,b   Chinopoulos, Christos ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Apoptosis; Bax; Calcium; Cytochrome c; Excitotoxicity

Indexed keywords

CASPASE; CINCHOCAINE; CYTOCHROME C; FREE RADICAL; NEUROTOXIN; PROPRANOLOL; PROTEIN BAX; PROTEINASE; REACTIVE OXYGEN METABOLITE; ROTENONE; SUPEROXIDE;

ANIMAL CELL; CELL DEATH; CELLULAR DISTRIBUTION; CONFERENCE PAPER; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; ELECTRON TRANSPORT; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE; NERVE CELL; NEUROPROTECTION; NONHUMAN; OLIGOMERIZATION; OXIDATION REDUCTION REACTION; PARKINSON DISEASE; PROTEIN DOMAIN; RESPIRATORY CHAIN;

ANIMALIA; PARKINSONIA;

EID: 0038389668     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2003.tb07469.x     Document Type: Conference Paper

References (36)

1. PARKER, W.D.J., S.J. BOYSON & J.K. PARKS. 1989. Abnormalities of the electron transport chain in idiopathic Parkinson's disease. Ann. Neurol. 26: 719-723.
2. SHULTS, C.W., R.H. HAAS, D. PASSOV & M.F. BEAL. 1997. Coenzyme Q10 levels correlate with the activities of complexes I and II/III in mitochondria from parkinsonian and nonparkinsonian subjects. Ann. Neurol. 42: 261-264.
3. SWERDLOW, R.H., J.K. PARKS, S.W. MILLER, et al. 1996. Origin and functional consequences of the complex I defect in Parkinson's disease. Ann. Neurol. 40: 663-671.
4. SHEEHAN, J.P., R.H. SWERDLOW, S.W. MILLER, et al. 1997. Calcium homeostasis and reactive oxygen species production in cells transformed by mitochondria from individuals with sporadic Alzheimer's disease. J. Neurosci. 17: 4612-4622.
5. TRIMMER, P.A., R.H. SWERDLOW, J.K. PARKS, et al. 2000. Abnormal mitochondrial morphology in sporadic Parkinson's and Alzheimer's disease cybrid cell lines. Exp. Neurol. 162: 37-50.
6. BETARBET, R., T.B. SHERER, G. MACKENZIE, et al. 2000. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 3: 1301-1306.
7. FISKUM, G. 2000. Mitochondrial participation in ischemic and traumatic neural cell death. J. Neurotrauma 17: 843-855.
8. QIU, J., M.J. WHALEN, P. LOWENSTEIN, et al. 2002. Upregulation of the Fas receptor death-inducing signaling complex after traumatic brain injury in mice and humans. J. Neurosci. 22: 3504-3511.
9. NAGATSU, T., M. MOGI, H. ICHINOSE & A. TOGARI. 2000. Changes in cytokines and neurotrophins in Parkinson's disease. J. Neural Transm. Suppl. 277-290.
10. FERRER, I., R. BLANCO, B. CUTILLAS & S. AMBROSIO. 2000. Fas and Fas-L expression in Huntington's disease and Parkinson's disease. Neuropathol. Appl. Neurobiol. 26: 424-433.
11. DAWSON, T.M. & V.L. DAWSON. 2002. Neuroprotective and neurorestorative strategies for Parkinson's disease. Nat. Neurosci. 5 Suppl.: 1058-1061.
12. FRIBERG, H. & T. WIELOCH. 2002. Mitochondrial permeability transition in acute neurodegeneration. Biochimie 84: 241-250.
13. KOWALTOWSKI, A.J., A.E. VERCESI & G. FISKUM. 2000. Bcl-2 prevents mitochondrial permeability transition and cytochrome c release via maintenance of reduced pyridine nucleotides. Cell Death. Differ. 7: 903-910.
14. SEATON, T.A., J.M. COOPER & A.H. SCHAPIRA. 1998. Cyclosporin inhibition of apoptosis induced by mitochondrial complex I toxins. Brain Res. 809: 12-17.
15. YANG, L., R.T. MATTHEWS, J.B. SCHULZ, et al. 1998. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyride neurotoxicity is attenuated in mice overexpressing Bcl-2. J. Neurosci. 18: 8145-8152.
16. ANDREYEV, A. & G. FISKUM. 1999. Calcium induced release of mitochondrial cytochrome c by different mechanisms selective for brain versus liver. Cell Death. Differ. 6: 825-832.
17. CHINOPOULOS, C., A.A. STARKOV & G. FISKUM. 2003. Cyclosporin A-insensitive permeability transition in brain mitochondria: inhibition by 2-aminoethoxydiphenyl borate. J. Biol. Chem. In press.
18. KORSMEYER, S.J., M.C. WEI, M. SAITO, et al. 2000. Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c. Cell Death Differ. 7: 1166-1173.
19. KUWANA, T., M.R. MACKEY, G. PERKINS, et al. 2002. Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane. Cell 111: 331-342.
20. POLSTER, B.M., K.W. KINNALLY & G. FISKUM. 2001. Bh3 death domain peptide induces cell type-selective mitochondrial outer membrane permeability. J. Biol. Chem. 276: 37887-37894.
21. VILA, M., V. JACKSON-LEWIS, S. VUKOSAVIC, et al. 2001. Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl- 4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. Proc. Natl. Acad. Sci. USA 98: 2837-2842.
22. POLSTER, B.M. & G. FISKUM. 2003. Inhibition of Bax-induced cytochrome c release from neural cell and brain mitochondria by dibucaine and propranolol. J. Neurosci. 23: 2735-2743.
23. MARTIN, L.J. 2001. Neuronal cell death in nervous system development, disease, and injury. Int. J. Mol. Med. 7: 455-478.
24. ARNOULT, D., P. PARONE, J.C. MARTINOU, et al. 2002. Mitochondrial release of apoptosis-inducing factor occurs downstream of cytochrome c release in response to several proapoptotic stimuli. J. Cell Biol. 159: 923-929.
25. STARKOV, A.A., B.M. POLSTER & G. FISKUM. 2002. Regulation of hydrogen peroxide production by brain mitochondria by calcium and Bax. J. Neurochem. 83: 220-228.
26. OUYANG, Y., S. CARRIEDO & R. GIFFARD. 2002. Effect of Bcl-X(L) overexpression on reactive oxygen species, intracellular calcium, and mitochondrial membrane potential following injury in astrocytes. Free Radic. Biol. Med. 33: 544.
27. CHENG, E.H., M.C. WEI, S. WEILER, et al. 2001. BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. Mol. Cell 8: 705-711.
28. ALKAYED, N.J., S. GOTO, N. SUGO, et al. 2001. Estrogen and Bcl-2: gene induction and effect of transgene in experimental stroke. J. Neurosci. 21: 7543-7550.
29. CAO, G., W. PEI, H. GE, et al. 2002. In vivo delivery of a Bcl-xL fusion protein containing the TAT protein transduction domain protects against ischemic brain injury and neuronal apoptosis. J. Neurosci. 22: 5423-5431.
30. BOVERIS, A. 1977. Mitochondrial production of superoxide radical and hydrogen peroxide. Adv. Exp. Med. Biol. 78: 67-82.
31. LENAZ, G., C. BOVINA, M. D'AURELIO, et al. 2002. Role of mitochondria in oxidative stress and aging. Ann. N.Y. Acad. Sci. 959: 199-213.
32. HILLERED, L. & L. ERNSTER. 1983. Respiratory activity of isolated rat brain mitochondria following in vitro exposure to oxygen radicals. J. Cereb. Blood Flow Metab. 3: 207-214.
33. NULTON-PERSSON, A.C. & L.I. SZWEDA. 2001. Modulation of mitochondrial function by hydrogen peroxide. J. Biol. Chem. 276: 23357-23361.
34. STARKOV, A. & G. FISKUM. 2002. Generation of reactive oxygen species by brain mitochondria mediated by alpha-ketoglutarate dehydrogenase. Soc. Neurosci. 194.17.
35. GAZARYAN, I.G., B.F. KRASNIKOV, G.A. ASHBY, et al. 2002. Zinc is a potent inhibitor of thiol oxidoreductase activity and stimulates reactive oxygen species production by lipoamide dehydrogenase. J. Biol. Chem. 277: 10064-10072.
36. GIBSON, G.E., L.C. PARK, K.F. SHEU, et al. 2000. The alpha-ketoglutarate dehydrogenase complex in neurodegeneration. Neurochem. Int. 36: 97-112.